Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets cautious ahead of risk events, Syria action

Wed, 04th Sep 2013 11:26

Traders adopted a cautious approach on Wednesday morning with UK stocks registering losses in morning trade ahead of a number of 'risk events' later in the week which have the potential to spark market volatility.Fears about impending US military action in Syria also hit investor sentiment today as support for a Western intervention continues to grow. Markets across Europe were trading in the red this morning, while stock futures in the US pointed to a weak start on Wall Street.The Senate Foreign Relations Committee last night gave the green light on a US attack on Syria, saying that the use of force "reflects the will and concerns of Democrats and Republicans alike". This comes ahead of the crucial vote in Congress next week on President Barack Obama's call for action against the Bashar al-Assad regime which he claims is responsible for the deadly chemical weapons attack against the Syrian people in August.It is set to be a busy end to the week with central-bank policy decisions expected on Thursday from the Bank of Japan, Bank of England and the European Central Bank. These will be followed by the all-important US jobs report on Friday which will be a large factor in the Federal Reserve's decision on whether or not to adjust current stimulus measures later this month.Services PMIs come in mixed"A combination of geopolitical concerns and hesitation before these big events forced us to look to economic data for fresh inspiration but readings from the Eurozone were less than impressive," said Market Strategist Ishaq Siddiqi from ETX Capital.After a series of better-than-expected manufacturing surveys from across the globe in recent days, data from the Eurozone services sector disappointed with activity growing by less than forecast in August. The Eurozone services purchasing managers' index (PMI) came in at 50.7, worse than the 51 estimate. Eurozone retail sales meanwhile increased by just 0.1% in July (forecast: +0.2%).In contrast, there was no letting up in the recent string of strong UK data this morning with the outlook for British economy continuing to brighten. The UK services PMI rose from 60.2 to 60.5 (forecast: 59.7), the highest level since December 2006."Following surprisingly strong gains in August's manufacturing and construction surveys, today's services result at face value points to quarterly [economic] growth in Q3 not far off a rip-roaring 2%," said Martin Beck, UK Economist from Capital Economics.FTSE 100: Airline stocks sink after Ryanair profit warningAirline peers easyJet and IAG were flying lower this morning after a gloomy outlook by Ryanair on the back of the hot weather in Northern Europe over the summer. The company scaled back its full-year profit guidance after worse-than-expected bookings but said that it could even fail to meet these forecasts if fares and yields continue to weaken over the coming winter.Hargreaves Lansdown fell despite reporting record annual figures this morning. Full-year pre-tax profit rose 28% to £195.2m as the financial services company took on more clients and increased assets under administration by 38% rise in AuA to £36.4bn. Weighing on the price this morning could be Morgan Stanley's downgrade of the 'Diversified Financial' sector to 'neutral'.TUI Travel, Resolution and BHP Billiton were also heavy fallers after going ex-dividend, meaning that from today new investors won't be able to get their hands on their latest dividend payments. Others that went ex-dividend on the blue-chip index include Admiral, Aggreko, ARM Holdings, IMI, Land Securities, Serco Group and Shire.Even chemicals group Croda International was lower after going ex-div, shrugging off an upgrade by Exane BNP Paribas to 'outperform'. Sector peer Johnson Matthey however was a high riser after JPMorgan Cazenove raised its target price from 2,600p to 2,800p. FTSE 250: Phoenix lower after going ex-divMicro Focus and Phoenix were among the worst performersthis morning after going ex-dividend. A host of others were also trading without the rights to their latest payouts, including 888 Holdings, Betfair, Elementis, esure, Greggs, Hikma Pharmaceuticals, Jardine Lloyd Thompson, Michael Page International, National Express Group, Polymetal International, Regus, SEGRO and Xaar.Kenmare Resources was higher after Goldman raised its recommendation to 'conviction buy', while Salamander Energy was boosted by a Morgan Stanley upgrade to 'equalweight'.FTSE 100 - RisersVodafone Group (VOD) 206.30p +1.88%Johnson Matthey (JMAT) 2,960.00p +1.47%Whitbread (WTB) 3,151.00p +1.06%Petrofac Ltd. (PFC) 1,410.00p +1.00%BG Group (BG.) 1,259.00p +0.96%Fresnillo (FRES) 1,288.00p +0.78%Experian (EXPN) 1,140.00p +0.53%Shire Plc (SHP) 2,398.00p +0.46%Intertek Group (ITRK) 3,246.00p +0.19%Rio Tinto (RIO) 3,064.00p +0.18%FTSE 100 - FallerseasyJet (EZJ) 1,200.00p -6.25%TUI Travel (TT.) 331.90p -3.99%Resolution Ltd. (RSL) 312.60p -3.93%International Consolidated Airlines Group SA (CDI) (IAG) 284.00p -3.63%Persimmon (PSN) 1,102.00p -3.50%Associated British Foods (ABF) 1,845.00p -2.95%Hargreaves Lansdown (HL.) 1,001.00p -2.91%Carnival (CCL) 2,316.00p -2.89%BHP Billiton (BLT) 1,890.00p -2.38%Standard Life (SL.) 331.90p -2.32%FTSE 250 - RisersBumi (BUMI) 223.00p +6.85%Kenmare Resources (KMR) 28.51p +4.82%Fisher (James) & Sons (FSJ) 1,136.00p +3.93%Enterprise Inns (ETI) 150.10p +3.88%Dechra Pharmaceuticals (DPH) 708.50p +2.98%COLT Group SA (COLT) 112.50p +2.93%St. Modwen Properties (SMP) 295.80p +2.74%Balfour Beatty (BBY) 262.70p +1.74%Smith (DS) (SMDS) 271.90p +1.64%Daejan Holdings (DJAN) 3,830.00p +1.46%FTSE 250 - FallersThomas Cook Group (TCG) 134.90p -5.40%Micro Focus International (MCRO) 731.50p -5.06%Ashtead Group (AHT) 654.00p -4.87%Phoenix Group Holdings (DI) (PHNX) 722.50p -4.30%Berkeley Group Holdings (The) (BKG) 2,083.00p -3.52%Barratt Developments (BDEV) 303.90p -3.52%Amlin (AML) 377.10p -3.28%Taylor Wimpey (TW.) 100.00p -3.01%Mitchells & Butlers (MAB) 433.90p -2.97%Diploma (DPLM) 618.00p -2.68%BC
More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.